Stephen H. Schwartz
Mr. Schwartz is a shareholder of the firm, which he joined in 2007 after fifteen years in New York city. He is admitted in both Pennsylvania and New York.
Charter Oak College, B.S. 1988
University of Pennsylvania, J.D. 1991
Mr. Schwartz is immersed in the firm’s anti-terrorism practice, and the work has taken him to Israel, Jordan, England and France. He was formerly with the Antitrust Department at Skadden Arps Slate Meagher & Flom. He was one of the lead attorneys in the Stock Exchanges Options Trading Antitrust Litigation (S.D.N.Y.), the Relafen Antitrust Litigation (D. Mass.), the Contact Lens Antitrust Litigation (M.D. Fla.), and the Old Country Buffets Securities Fraud Litigation (D. Minn.) He also played major roles in the Terazosin Hydrochloride Antitrust Litigation (S.D. Fla.), the Nasdaq Market Makers Antitrust Litigation (S.D.N.Y.), the Brand Name Drug Antitrust Litigation (N.D. Ill.), the Computer Associates Derivative Litigation (Del. Chancery), and the Salomon Inc. Shareholders’ Derivative Litigation (S.D.N.Y.).
Representative opinions: Linde V. Arab Bank, PLC,_F.Supp.3d_, 2015 WL 1565479 (E.D.N.Y 2015) (Post-trial motions), Weiss v. National Westminister Bank PLC, 768 F.3d202 (2d Cir. 2014)(standard for scienter under Anti_Terrorism Act), Strauss v. Credit Lyonnais, 925 F.Supp.2d 414 (E.D.N.Y. 2013)(summary judgment), Linde v. Arab Bank, PLC, 706 F.3d 92 (2d Cir. 2013)(collateral order doctrine, mandamus); Gill v. Arab Bank, PLC, 893 F.Supp.2d 523 (E.D.N.Y 2012)(qualification of experts), Goldberg v. UBS AG, 690 F.Supp. 2d 92 (E.D.N.Y. 2010)(reconsideration, interlocutory appeal), Strauss V. Credit Lyonnais, 249 F.R.D 429 (E.D.N.Y 2008)(foreign discovery), In re Terazosin Hydrochloride Antitrust Litigation, 220 F.R.D. 672 (S.D. Fla 2004)(class certification), In re Stock Exchange Options Trading Antitrust Litigation, 317 F.3d 134 (2d Cir. 2003)(Implied repeal of Sherman Act by Securities Exchange Act, federal jurisdiction).